Home › Asset managers › Compare 2025-2026 › Vanguard vs Charles Schwab
Vanguard 2025-2026 · Charles Schwab 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 33,754 | 30,065 | 1,248 | 2,441 | 96.0% | 93.8% |
| Board proposals | 30,259 | 26,946 | 1,155 | 2,158 | 95.9% | 93.7% |
| E&S shareholder proposals | 193 | 164 | 5 | 24 | 97.0% | 95.7% |
| Other items | 3,302 | 2,955 | 88 | 259 | 97.1% | 94.8% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
2,158 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Vanguard | Charles Schwab |
|---|---|---|---|---|---|---|
| 3D SYSTEMS CORPORATION | May 14, 2026 | The approval of an amendment to our Certificate of Incorporation, as amended, to increase the total number of authorized shares of our common stock, par value $0.001 per share, from 220,000,000 shares to 440,000,000 shares. Capital Structure |
Board | For | Split 8 FOR, 2 AGAINST |
FOR 4 funds |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The approval of the amendment and restatement of the 2015 Incentive Plan to increase the number of shares reserved for issuance thereunder by 4,000,000 shares and to extend the term until 2036. Compensation |
Board | For | Split 7 FOR, 3 AGAINST |
FOR 4 funds |
| 908 DEVICES INC | June 11, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 10 FOR, 1 AGAINST |
FOR 5 funds |
| A. O. Smith Corporation | April 13, 2026 | Elect Ilham Kadri Director Elections |
Board | For | Split 8 FOR, 1 WITHHOLD |
WITHHOLD 14 funds |
| A10 NETWORKS, INC. | April 22, 2026 | To approve, on an advisory and non-binding basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 24 FOR, 1 AGAINST |
FOR 5 funds |
| AAON, INC. | May 12, 2026 | Election of Directors for a term ending in 2029: Stephen O. LeClair Director Elections |
Board | For | Split 15 FOR, 1 AGAINST |
FOR 11 funds |
| ABACUS GLOBAL MANAGEMENT, INC. | June 3, 2026 | Approval, by an advisory vote, of the compensation of the Company's Named Executive Officers. Say-on-Pay |
Board | For | Split 1 FOR, 12 AGAINST |
AGAINST 5 funds |
| ABEONA THERAPEUTICS INC. | June 12, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 9 FOR, 1 AGAINST |
FOR 3 funds |
| ABERCROMBIE & FITCH CO. | June 3, 2026 | Advisory vote to approve the compensation of the Company's named executive officers for the fiscal year ended January 31, 2026. Say-on-Pay |
Board | For | Split 27 FOR, 6 AGAINST |
FOR 10 funds |
| ABM INDUSTRIES INCORPORATED | March 25, 2026 | Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending October 31, 2026. Audit-related |
Board | For | Split 17 FOR, 4 AGAINST |
FOR 7 funds |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares. Compensation |
Board | For | Split 28 FOR, 4 AGAINST |
FOR 5 funds |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Approval of 2026 Equity Incentive Plan. Compensation |
Board | For | Split 18 FOR, 4 AGAINST |
FOR 8 funds |
| ACCENDRA HEALTH, INC. | May 14, 2026 | Non-Binding advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 16 FOR, 2 AGAINST |
FOR 8 funds |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Arun Sarin Director Elections |
Board | For | Split 37 FOR, 1 AGAINST |
FOR 14 funds |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Nancy McKinstry Director Elections |
Board | For | Split 37 FOR, 1 AGAINST |
FOR 14 funds |
| ACCENTURE PLC | January 28, 2026 | To approve, in a non-binding vote, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 49 FOR, 9 AGAINST |
FOR 16 funds |
| ACCENTURE PLC | January 28, 2026 | To ratify, in a non-binding vote, the appointment of KPMG LLP ("KPMG") as independent auditor of Accenture and to authorize, in a binding vote, the Audit Committee of the Board of Directors to determine KPMG's remuneration. Audit-related |
Board | For | Split 43 FOR, 2 AGAINST |
FOR 14 funds |
| ACCO BRANDS CORPORATION | May 19, 2026 | Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for 2026. Audit-related |
Board | For | Split 10 FOR, 2 AGAINST |
FOR 7 funds |
| ACI WORLDWIDE, INC. | June 2, 2026 | To conduct an advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | Split 7 FOR, 4 AGAINST |
FOR 11 funds |
| ACLARIS THERAPEUTICS, INC. | June 4, 2026 | Elect Anand Mehra Director Elections |
Board | For | Split 1 FOR, 1 WITHHOLD |
FOR 2 funds |
| ACLARIS THERAPEUTICS, INC. | June 4, 2026 | Elect Maxine Gowen Director Elections |
Board | For | Split 1 FOR, 1 WITHHOLD |
FOR 2 funds |
| ACLARIS THERAPEUTICS, INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying the proxy card. Say-on-Pay |
Board | For | Split 10 FOR, 1 AGAINST |
FOR 3 funds |
| ACRES COMMERCIAL REALTY CORP. | June 22, 2026 | APPROVE A PROPOSAL TO ADOPT THE ACRES COMMERCIAL REALTY CORP. 2026 OMNIBUS EQUITY INCENTIVE PLAN. Compensation |
Board | For | Split 7 FOR, 1 AGAINST |
FOR 2 funds |
| ADAMAS TRUST, INC. | June 11, 2026 | To approve an amendment to the Company's 2017 Equity Incentive Plan, as amended. Compensation |
Board | For | Split 11 FOR, 4 AGAINST |
FOR 7 funds |
| ADAPTHEALTH CORP. | June 18, 2026 | Elect Bradley J. Coppens Director Elections |
Board | For | Split 6 FOR, 6 WITHHOLD |
FOR 7 funds |
| ADAPTHEALTH CORP. | June 18, 2026 | Elect David Williams III Director Elections |
Board | For | Split 6 FOR, 6 WITHHOLD |
FOR 7 funds |
| ADAPTHEALTH CORP. | June 18, 2026 | Elect Gregory Belinfanti Director Elections |
Board | For | Split 6 FOR, 6 WITHHOLD |
FOR 7 funds |
| ADAPTHEALTH CORP. | June 18, 2026 | Elect Susan T. Weaver Director Elections |
Board | For | Split 6 FOR, 6 WITHHOLD |
FOR 7 funds |
| ADAPTHEALTH CORP. | June 18, 2026 | Elect Terence J. Connors Director Elections |
Board | For | Split 6 FOR, 6 WITHHOLD |
FOR 7 funds |
| ADDUS HOMECARE CORPORATION | June 10, 2026 | To approve, on an advisory, non-binding basis, the compensation of the named executive officers. Say-on-Pay |
Board | For | Split 17 FOR, 4 AGAINST |
FOR 9 funds |
| ADEIA INC. | May 7, 2026 | To approve an amendment to the Amended and Restated 2020 Equity Incentive Plan to increase the number of shares reserved for issuance by an additional 10,700,000 shares of common stock; and Compensation |
Board | For | Split 20 FOR, 5 AGAINST |
FOR 4 funds |
| ADOBE INC. | April 15, 2026 | Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 33 FOR, 11 AGAINST |
AGAINST 15 funds |
| ADT Inc. | May 27, 2026 | Election of Directors To be elected for terms expiring in 2027: Danielle Tiedt Director Elections |
Board | For | Split 24 FOR, 1 WITHHOLD |
FOR 13 funds |
| ADTRAN HOLDINGS, INC. | May 13, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. Audit-related |
Board | For | Split 14 FOR, 2 AGAINST |
FOR 4 funds |
| ADVANCE AUTO PARTS, INC. | May 20, 2026 | Ratify the appointment of Deloitte & Touche LLP (Deloitte) as our independent registered public accounting firm for 2026. Audit-related |
Board | For | Split 18 FOR, 6 AGAINST |
FOR 6 funds |
| ADVANCED DRAINAGE SYSTEMS, INC. | July 17, 2025 | Approval, in a non-binding advisory vote, of the compensation for named executive officers. Say-on-Pay |
Board | For | Split 26 FOR, 4 AGAINST |
FOR 16 funds |
| ADVANCED ENERGY INDUSTRIES, INC. | May 7, 2026 | Approval of an amendment to the Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 70,000,000 shares to 140,000,000 shares; Capital Structure |
Board | For | Split 17 FOR, 5 AGAINST |
FOR 10 funds |
| ADVANSIX INC | June 22, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accountants for 2026. Audit-related |
Board | For | Split 9 FOR, 2 AGAINST |
FOR 7 funds |
| AERSALE CORPORATION | June 11, 2026 | Approval of the redomestication of the Company from Delaware to Texas by conversion. Extraordinary Transactions |
Board | For | Split 2 FOR, 9 AGAINST |
FOR 2 funds |
| AERSALE CORPORATION | June 11, 2026 | Approval, on an advisory basis, of the Company's named executive officer compensation. Compensation |
Board | For | Split 13 FOR, 1 AGAINST |
FOR 3 funds |
| AFFILIATED MANAGERS GROUP, INC. | May 27, 2026 | To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year. Audit-related |
Board | For | Split 22 FOR, 7 AGAINST |
FOR 11 funds |
| AGENUS INC. | June 16, 2026 | To approve a one-time stock option exchange program under our 2019 EIP, our Amended and Restated 2009 Equity Incentive Plan, and our 2015 Inducement Equity Plan, with premium strike prices applicable to director and executive officer replacement options. Compensation |
Board | For | Split 5 FOR, 4 AGAINST |
AGAINST 1 fund |
| AGENUS INC. | June 16, 2026 | To approve an amendment to our Amended and Restated 2019 Equity Incentive Plan to increase the aggregate shares available for issuance by 5,000,000 shares. Compensation |
Board | For | Split 8 FOR, 1 AGAINST |
FOR 1 fund |
| AGENUS INC. | June 16, 2026 | To approve, in a non-binding advisory vote, the compensation of the Company's named executive officers for 2025 (Say-on-Pay). Say-on-Pay |
Board | For | Split 11 FOR, 1 AGAINST |
AGAINST 2 funds |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, as Amended, to increase the number of shares of common stock available thereunder by 2,000,000 shares. Compensation |
Board | For | Split 14 FOR, 3 AGAINST |
FOR 4 funds |
| AIRGAIN INC | June 10, 2026 | To approve the amendment and restatement of the 2016 Incentive Award Plan. Compensation |
Board | For | Split 2 FOR, 1 AGAINST |
FOR 1 fund |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | Split 17 FOR, 6 AGAINST |
FOR 14 funds |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay |
Board | For | Split 22 FOR, 6 AGAINST |
FOR 16 funds |
| AKEBIA THERAPEUTICS, INC. | June 17, 2026 | Elect Michael Rogers Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 3 funds |
| AKERO THERAPEUTICS, INC | December 2, 2025 | To approve, on an advisory, non-binding basis, the payment of certain compensation that may be paid or become payable by Akero to its named executive officers in connection with the Merger. Say-on-Pay |
Board | Contested | Split 15 FOR, 1 AGAINST |
FOR 5 funds |
| ALDEYRA THERAPEUTICS, INC. | June 9, 2026 | Election of Class III Director: Todd C. Brady, M.D., Ph.D. Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 2 funds |
| ALECTOR, INC. | June 17, 2026 | Elect Elizabeth A. Garofalo Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 4 funds |
| ALEXANDER'S, INC. | May 21, 2026 | Non-Binding Advisory Resolution on Executive Compensation. Say-on-Pay |
Board | For | Split 17 FOR, 1 AGAINST |
FOR 7 funds |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | May 13, 2026 | To cast a non-binding, advisory vote on a resolution to approve the compensation of the Company's named executive officers, as more particularly described in the accompanying Proxy Statement. Say-on-Pay |
Board | For | Split 24 FOR, 4 AGAINST |
FOR 17 funds |
| ALIGHT, INC. | June 10, 2026 | To approve, on an advisory (non-binding) basis, the 2025 compensation paid to our named executive officers. Say-on-Pay |
Board | For | Split 20 FOR, 2 AGAINST |
FOR 6 funds |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | Advisory Vote to Approve the Compensation of our Named Executive Officers Say-on-Pay |
Board | For | Split 28 FOR, 7 AGAINST |
FOR 15 funds |
| ALKERMES PLC | May 20, 2026 | To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended. Compensation |
Board | For | Split 25 FOR, 5 AGAINST |
FOR 8 funds |
| ALLEGRO MICROSYSTEMS, INC. | August 7, 2025 | To approve, on an advisory basis, the Company's executive compensation. Say-on-Pay |
Board | For | Split 23 FOR, 3 AGAINST |
FOR 11 funds |
| ALLOGENE THERAPEUTICS, INC. | June 18, 2026 | To approve an amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of common stock from 400,000,000 shares to 800,000,000 shares. Capital Structure |
Board | For | Split 10 FOR, 2 AGAINST |
FOR 4 funds |
| ALLY FINANCIAL INC. | May 6, 2026 | Approval of the Ally Financial Inc. Incentive Compensation Omnibus Plan. Compensation |
Board | For | Split 28 FOR, 1 AGAINST |
FOR 13 funds |
| ALNYLAM PHARMACEUTICALS, INC. | May 20, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2026. Audit-related |
Board | For | Split 30 FOR, 3 AGAINST |
FOR 9 funds |
| ALPHABET INC. | June 5, 2026 | Advisory vote to approve compensation awarded to named executive officers Say-on-Pay |
Board | For | Split 26 FOR, 29 AGAINST |
AGAINST 19 funds |
| ALPHABET INC. | June 5, 2026 | Approval of the amendment and restatement of Alphabet's Amended and Restated 2021 Stock Plan to increase the share reserve by 200,000,000 shares of Class C capital stock Compensation |
Board | For | Split 39 FOR, 9 AGAINST |
FOR 16 funds |
| ALPHABET INC. | June 5, 2026 | Ratification of appointment of Ernst & Young LLP as Alphabet's independent registered public accounting firm for the fiscal year ending December 31, 2026 Audit-related |
Board | For | Split 51 FOR, 1 AGAINST |
FOR 16 funds |
| ALTA EQUIPMENT GROUP INC. | May 29, 2026 | To approve the First Amendment to Alta Equipment Group, Inc 2020 Omnibus Incentive Plan Compensation |
Board | For | Split 7 FOR, 3 AGAINST |
FOR 2 funds |
| ALTI GLOBAL, INC. | June 17, 2026 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ended December 31, 2026. Audit-related |
Board | For | Split 6 FOR, 1 AGAINST |
FOR 4 funds |
| ALTIMMUNE INC. | April 16, 2026 | Elect John M. Gill Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 2 funds |
| ALTIMMUNE INC. | April 16, 2026 | Elect Klaus O. Schafer Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 2 funds |
| ALTIMMUNE INC. | April 16, 2026 | Elect Mitchel B. Sayare Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 2 funds |
| ALTIMMUNE INC. | April 16, 2026 | Elect Wayne Pisano Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 2 funds |
| ALTO NEUROSCIENCE, INC. | May 12, 2026 | To approve an amendment and restatement of the Company's 2024 Employee Stock Purchase Plan to treat outstanding pre-funded warrants the same as outstanding shares of Common Stock for purposes of calculating the number of shares to be automatically added to the share reserve thereunder pursuant to the "evergreen" feature of the 2024 Employee Stock Purchase Plan. Capital Structure |
Board | For | Split 3 FOR, 1 AGAINST |
AGAINST 1 fund |
| AMAZON.COM, INC. | May 20, 2026 | RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS Audit-related |
Board | For | Split 48 FOR, 2 AGAINST |
FOR 15 funds |
| AMBARELLA, INC. | June 26, 2026 | To approve an amendment and restatement of the Ambarella, Inc. 2021 Equity Incentive Plan. Compensation |
Board | For | Split 15 FOR, 1 AGAINST |
AGAINST 5 funds |
| AMC GLOBAL MEDIA INC. | June 16, 2026 | Elect Matthew C. Blank Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 8 funds |
| AMC GLOBAL MEDIA INC. | June 16, 2026 | Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for 2026 Audit-related |
Board | For | Split 10 FOR, 1 AGAINST |
FOR 8 funds |
| AMDOCS LIMITED | January 30, 2026 | To ratify and approve the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2026, and until the next annual general meeting, and authorize the Audit Committee of the Board of Directors to fix the remuneration of such independent registered public accounting firm in accordance with the nature and extent of its services (Proposal V). Audit-related |
Board | For | Split 5 FOR, 1 AGAINST |
FOR 7 funds |
| AMERANT BANCORP INC. | June 2, 2026 | Election of Director to serve until the 2027 annual meeting of shareholders: Erin D. Knight Director Elections |
Board | For | Split 2 FOR, 2 AGAINST |
FOR 5 funds |
| AMERANT BANCORP INC. | June 2, 2026 | Election of Director to serve until the 2027 annual meeting of shareholders: Oscar Suarez Director Elections |
Board | For | Split 2 FOR, 2 AGAINST |
FOR 5 funds |
| AMERICAN AIRLINES GROUP INC. | June 10, 2026 | A proposal to approve, on a non-binding, advisory basis, executive compensation as disclosed in the Proxy Statement for the 2026 Annual Meeting of Stockholders Say-on-Pay |
Board | For | Split 29 FOR, 5 AGAINST |
FOR 14 funds |
| AMERICAN ASSETS TRUST, INC. | June 1, 2026 | Elect Robert S. Sullivan Director Elections |
Board | For | Split 4 FOR, 4 WITHHOLD |
FOR 11 funds |
| AMERICAN ASSETS TRUST, INC. | June 1, 2026 | Elect Thomas S. Olinger Director Elections |
Board | For | Split 4 FOR, 4 WITHHOLD |
FOR 11 funds |
| AMERICAN EXPRESS COMPANY | May 5, 2026 | Approval, on an advisory basis, of the Company's executive compensation. Say-on-Pay |
Board | For | Split 42 FOR, 4 AGAINST |
FOR 16 funds |
| AMERICAN INTERNATIONAL GROUP, INC. | May 13, 2026 | Advisory Vote to Approve Named Executive Officer Compensation. Say-on-Pay |
Board | For | Split 43 FOR, 5 AGAINST |
FOR 13 funds |
| AMERICAN INTERNATIONAL GROUP, INC. | May 13, 2026 | Ratify Appointment of PricewaterhouseCoopers LLP to Serve as Independent Auditor for 2026. Audit-related |
Board | For | Split 33 FOR, 9 AGAINST |
FOR 12 funds |
| AMERICOLD REALTY TRUST, INC. | May 18, 2026 | Ratification of Ernst & Young LLP as our Independent Accounting Firm for 2026. Audit-related |
Board | For | Split 16 FOR, 2 AGAINST |
FOR 11 funds |
| AMERIPRISE FINANCIAL, INC. | April 29, 2026 | To approve the compensation of the named executive officers by a nonbinding advisory vote. Say-on-Pay |
Board | For | Split 32 FOR, 11 AGAINST |
FOR 16 funds |
| AMICUS THERAPEUTICS, INC. | March 3, 2026 | To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger. Say-on-Pay |
Board | For | Split 16 FOR, 1 AGAINST |
FOR 5 funds |
| AMN HEALTHCARE SERVICES, INC. | May 1, 2026 | To approve, by non-binding advisory vote, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | Split 21 FOR, 4 AGAINST |
AGAINST 8 funds |
| AMPLIFY ENERGY CORP. | June 3, 2026 | To approve the Amplify Energy Corp. 2024 Amended and Restated Equity Incentive Plan. Compensation |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 1 fund |
| AMPLITUDE, INC. | June 9, 2026 | Elect Catherine Wong Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 3 funds |
| AMPLITUDE, INC. | June 9, 2026 | Elect Curtis Liu Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 3 funds |
| AMPLITUDE, INC. | June 9, 2026 | Elect Patrick Grady Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 3 funds |
| AMYLYX PHARMACEUTICALS, INC. | June 4, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 16 FOR, 1 AGAINST |
FOR 5 funds |
| ANALOG DEVICES, INC. | March 11, 2026 | Approve the Amended and Restated Analog Devices, Inc. 2020 Equity Incentive Plan. Compensation |
Board | For | Split 31 FOR, 6 AGAINST |
FOR 12 funds |
| ANDERSEN GROUP INC. | June 22, 2026 | To ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 1 fund |
| ANGI INC. | June 10, 2026 | Approval of the Amended and Restated Angi Inc. 2017 Stock and Annual Incentive Plan. Compensation |
Board | For | Split 10 FOR, 1 AGAINST |
FOR 7 funds |
| ANGI INC. | June 10, 2026 | Elect Sandra Buchanan Hurse Director Elections |
Board | For | Split 2 FOR, 2 WITHHOLD |
FOR 7 funds |
| ANGI INC. | June 10, 2026 | Ratification of the appointment of Ernst & Young LLP as Angi Inc.'s independent registered public accounting firm for the 2026 fiscal year. Audit-related |
Board | For | Split 10 FOR, 1 AGAINST |
FOR 7 funds |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the Amended and Restated 2022 Stock Incentive Plan. Compensation |
Board | For | Split 14 FOR, 4 AGAINST |
FOR 6 funds |
| ANIKA THERAPEUTICS, INC. | June 18, 2026 | Approval of the Amendment to the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan. Compensation |
Board | For | Split 6 FOR, 1 AGAINST |
FOR 4 funds |
Page 1 of 22 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.